Conceptual · Article 7.2.10

Disease-Specific Health Plans.

One Named Enemy, Covered in Depth.

Published as on 24 July 2026

A disease-specific plan is health insurance built around a single condition — cancer, diabetes, cardiac disease, kidney failure, or a vector-borne illness like dengue or malaria. Unlike a comprehensive mediclaim policy, which covers all hospitalisation broadly, or a critical illness policy, which pays one lump sum on diagnosis and stops, a disease-specific plan tracks the actual treatment journey of one named disease — surgery, chemotherapy cycles, dialysis sessions, complications and all. Governed by IRDAI, these plans come in two shapes: benefit-based (a fixed payout on a defined event, stackable across insurers) and indemnity (reimbursement of real bills). Since the April 2024 regulations, the maximum pre-existing waiting period is 36 months and insurers can no longer refuse the very conditions these plans exist to cover. Read them as a second, deeper layer over a base policy — never as the base policy itself.

14.6 lakh

New Cancer Cases · 2022

₹59–₹682

Dengue/Malaria Premium · yr

36 months

Max PED Wait · Post 2024

Section 80D

Old Regime Only

Executive Summary · Page 2

Executive Summary · 6 Findings

A disease-specific plan answers a narrow question: I know which disease frightens me most — how do I insure against that one, in depth? Where comprehensive mediclaim spreads a fixed sum insured thinly across every possible ailment, a disease-specific plan concentrates cover on a single named condition and follows it through the whole arc of treatment. The catch: depth on one disease is not breadth across all of them. These plans work only as a supplement to a solid base policy, never as a substitute for it.

Covers what a disease-specific plan is and the coverage gap it fills, the benefit-versus-indemnity distinction that decides whether payouts stack, the major Indian categories — cancer, cardiac, diabetes, kidney/dialysis and vector-borne cover — the waiting-period and no-refusal framework after IRDAI's April 2024 regulations, how these plans differ from mediclaim and critical illness cover, Section 80D and Section 80DDB tax treatment, who should actually buy one, and six questions Indian buyers ask.

Key Findings

Depth on one disease, not breadth across all.

A disease-specific plan insures a single named condition — cancer, diabetes, cardiac, renal, dengue — and covers its full treatment journey: multiple procedures, stages and complications. It sits under IRDAI's health framework, distinct from broad mediclaim and from a one-shot critical illness payout. Its purpose is concentrated cover for a known, high-cost risk.

Benefit-based plans stack; indemnity plans don't.

Benefit-based cover pays a fixed sum on a defined event — diagnosis or a qualifying hospitalisation — regardless of the bill, and under IRDAI's 2024 framework you can claim from multiple insurers at once. Indemnity cover reimburses actual expenses, so coordination of benefits caps the total across all policies at the real bill. This one distinction decides whether two policies add up or overlap.

Five categories cover most of India's disease burden.

Cancer plans pay across stages and treatment lines; cardiac plans span angioplasty to bypass; diabetes plans cover the complications standard mediclaim excludes; kidney plans fund lifelong dialysis and transplant; and vector-borne plans pay a lump sum on a confirmed dengue, malaria or chikungunya diagnosis — from as little as ₹59 a year.

April 2024 changed the rules in the buyer's favour.

IRDAI's 2024 regulations cut the maximum pre-existing disease waiting period to 36 months, set the moratorium at 60 months, and — crucially — barred insurers from refusing cover for cancer, diabetes, heart disease, kidney failure and HIV/AIDS. They may load the premium or apply a temporary exclusion, but they can no longer say no.

A supplement, never a replacement.

A disease-specific plan is a second layer, not a foundation. The right structure is comprehensive mediclaim as the primary hospitalisation cover, with a disease-specific plan bolted on for the one risk you genuinely fear — a family cancer history, an existing diabetes diagnosis, a high-incidence dengue zone. Build the base first.

Premiums qualify for Section 80D — old regime only.

Because they are health insurance, premiums count toward the Section 80D deduction: ₹25,000 for a family under 60, ₹50,000 where a senior is insured — but only under the old tax regime. Section 80DDB, a separate deduction for out-of-pocket treatment of specified diseases, can be claimed alongside it, subject to its own limits.

At A Glance

Metric	Value	Detail
Regulator	IRDAI	Health framework
Scope	One disease	Or a related group
Structure	Benefit / Indemnity	Stackable if benefit
PED Wait	36 months	Post April 2024
Initial Wait	90 days	Accidents exempt
Moratorium	60 months	No repudiation after
Tax	Section 80D	Old regime only
Role	Supplement	Not a base policy

Exhibit 01: The Cost Range Across Categories

Category	Structure	Typical Premium
Dengue / Malaria	Benefit	₹59–₹682/yr
Cancer	Multi-stage	Moderate
Cardiac	Per-procedure	Moderate
Diabetes	Indemnity + waiver	Higher (loaded)

*Illustrative, FY 2025-26. Vector-borne plans are the lowest-cost disease cover in India. Diabetes plans for existing diabetics carry premium loading in exchange for a shortened waiting period. Premiums vary by insurer, age, sum insured and underwriting.

The Opening · Page 3

The Opening

India's disease burden is lopsided in a way that ordinary insurance handles badly. The ICMR registered roughly 14.6 lakh new cancer cases in 2022; more than 10 crore Indians live with diabetes; cardiac events remain the leading killer of urban professionals; and dengue and malaria hospitalise millions every monsoon. A comprehensive mediclaim policy spreads one sum insured thinly across all of it. A disease-specific plan does the opposite: it takes a single named disease and insures it in depth — a cancer plan pays across chemotherapy cycles, radiation and transplants; a diabetes plan covers the nephropathy and retinopathy that standard mediclaim quietly excludes; a dengue plan drops a fixed cheque on a confirmed positive test.

"Comprehensive cover asks 'were you hospitalised?' A disease-specific plan asks 'is it the disease you feared?' — and when the answer is yes, it follows that disease through every stage of treatment rather than rationing one shared sum insured."
Depth Over Breadth

Two structures, one crucial difference. A benefit-based plan pays a pre-agreed amount when a defined event occurs — a diagnosis, a positive test, a qualifying hospitalisation — with no reference to the actual bill. Because the payout isn't tied to expenses, IRDAI's 2024 framework lets you claim the defined benefit from several insurers at once; benefit-based plans stack. An indemnity plan reimburses real costs up to the sum insured, so coordination of benefits caps the combined payout across all policies at your actual hospital bill.

The 2024 reset. IRDAI's (Insurance Products) Regulations, effective 1 April 2024, cut the maximum pre-existing waiting period to 36 months and — the decisive change — prohibited insurers from refusing to issue health cover for severe conditions including cancer, diabetes, heart disease, kidney failure and AIDS. The door that used to slam on the sickest applicants is now legally propped open.

The Honest Boundary: A disease-specific plan is NOT your primary health cover — it insures one disease, not the other hundred. It is NOT a critical illness policy — it pays across a treatment journey, not once on diagnosis. It is NOT a reason to skip comprehensive mediclaim. It IS a sharp, cost-effective second layer for a single high-cost risk you have real reason to fear — provided the base policy is already in place.

Structure

Part I

What These Plans Are, the Gap They Fill & Benefit vs Indemnity

Part II

The Five Categories & the Waiting-Period Framework

Part III

vs Mediclaim & CI, the Tax Rules & Who Should Buy

Part IV

The Verdict: A Second Layer, Placed Deliberately

Consider If

✓ A base health policy is already in place

✓ You face one clear, elevated disease risk

✓ Family history or an existing diagnosis

✓ Your base plan sub-limits fall short

Reconsider If

✕ You have no comprehensive cover yet

✕ You want it to replace mediclaim

✕ You expect broad, any-illness cover

✕ You cannot wait out the PED period

Part I

What a Disease-Specific Plan Is, the Gap It Fills, and Why Structure Decides Everything

How focused cover follows a single disease through its whole treatment arc where broad mediclaim cannot; and why the benefit-versus-indemnity distinction — not the disease itself — determines whether two policies stack or merely overlap.

Part I · Page 4

The Coverage Gap

A standard mediclaim policy is broad but shallow on any single disease. For a chronic or high-cost condition, its structure fails in predictable ways: chemotherapy may be treated as day-care with sub-limits; targeted-therapy drugs may sit outside cover; a bone-marrow transplant can exhaust the annual sum insured in one cycle; diabetic complications may be excluded or heavily waited. A disease-specific plan is engineered around the actual treatment protocol for its one disease — which is precisely where the broad policy runs thin.

What Focused Cover Adds

A cancer plan covers surgery and chemotherapy cycles, radiation, targeted therapy, transplants and reconstruction — often across several policy years. A diabetes plan explicitly covers nephropathy, retinopathy and foot care. A dengue plan pays a fixed sum on a confirmed positive test. A cardiac plan sets per-procedure limits calibrated to real cardiac costs, not general package rates.

Benefit vs Indemnity

Benefit-Based — Stackable

A pre-agreed sum is paid on a defined event, independent of the bill. Under IRDAI's 2024 framework, claims can run across multiple insurers simultaneously — each pays its benefit, and the aggregate is not capped at actual expenses.

Indemnity-Based — Coordinated

Actual hospitalisation expenses are reimbursed up to the sum insured. Coordination of benefits applies: hold several policies and the combined reimbursement still cannot exceed the real hospital bill.

Where It Sits in the Stack

Layer	Cover	Role
Base	Comprehensive mediclaim	Primary cover
Focused	Disease-specific plan	Depth on one risk
Catastrophe	Critical illness	Lump-sum buffer
Top-up	Super top-up	High-cost excess
Emergency	Cash reserve	Immediate liquidity

The disease-specific plan is the focused layer — it presumes a base policy beneath it and adds concentrated cover for a single named risk. The guiding rule is base first, focus second: comprehensive mediclaim as the foundation, then a dedicated plan for the disease you have genuine reason to fear.

Appropriate uses: a cancer plan alongside mediclaim for someone with a strong family cancer history; a diabetes plan for an existing diabetic whose base policy excludes complications; a dengue plan for a household in a high-incidence city. Inappropriate: buying a cancer plan instead of comprehensive cover — that leaves every other illness uninsured.

Part II

The Five Categories and the Waiting-Period Framework After April 2024

Cancer, cardiac, diabetes, kidney and vector-borne cover — what each is built for; and the initial, pre-existing and moratorium waiting periods, alongside IRDAI's decisive prohibition on refusing the very conditions these plans insure.

Part II · Page 6

The Major Categories

Cancer — The Most Developed Segment

Dedicated cancer plans pay across stages — early-stage and carcinoma-in-situ at one level, major stage at a higher one — with per-treatment benefits for chemotherapy and radiation, and cover that continues rather than terminating after the first payout. Star Health's Cancer Care (Platinum) is one such market product.

Cardiac & Kidney

Cardiac plans span angioplasty, stenting, bypass (CABG), valve procedures and implantable devices — useful for those with hypertension or a family history who face loading on standard cover. Kidney plans fund lifelong dialysis (often ~3 sessions a week), transplant surgery and anti-rejection medication.

Diabetes & Vector-Borne

Diabetes plans — such as Star Health's Diabetes Safe — cover nephropathy, retinopathy, neuropathy and foot care, and some let existing diabetics shorten the wait to 24–31 days for a higher premium. Vector-borne plans (e.g. Bajaj Allianz Mosquito Care) pay ₹50,000–₹1 lakh on a confirmed dengue, malaria or chikungunya diagnosis with the required hospitalisation, from ₹59–₹682 a year.

Product names are illustrative examples of available cover, not recommendations. COVID-specific plans (Corona Kavach and Corona Rakshak) were mandated only through September 2021 and are no longer sold; HIV/AIDS cover is now available following the 2024 no-refusal rule.

The Waiting Periods (Post April 2024)

Period	Duration	Effect
Initial	90 days	No claims except accidents
Pre-existing (PED)	36 months	Down from 48
Moratorium	60 months	No repudiation after
Diabetes waiver	24–31 days	Select plans, loaded

The Prohibition on Refusal

IRDAI's 2024 regulations bar insurers from refusing to issue health cover on grounds of severe pre-existing conditions — including cancer, diabetes, heart disease, kidney failure and AIDS. They may apply premium loading or a temporary exclusion for the 36-month PED window, but they cannot refuse the policy outright.

After the Waits Run Out

Once 36 months of continuous cover elapse, the pre-existing condition itself must be fully covered. After 60 months, an insurer cannot deny a covered claim for non-disclosure or misrepresentation — except in proven fraud. Continuity of cover is what unlocks the plan's full value.

Part III

Against Mediclaim and Critical Illness, the Tax Position, and Who Should Actually Buy

Where a disease-specific plan differs from broad mediclaim and from a one-shot critical illness payout; how Section 80D and the separate Section 80DDB apply under the old regime; and the specific circumstances in which this second layer earns its premium.

Part III · Page 8

Three Structures Compared

Factor	Disease-Specific	Mediclaim	CI Policy
Scope	One disease	All hospitalisation	~10–60 illnesses
Payout	Benefit / indemnity	Indemnity	Lump sum
Early stage	Often covered	Not specific	Excluded
Continues	Yes	Yes	Ends on claim
Role	Focused depth	Primary cover	Cash buffer

vs Critical Illness — The Key Difference

A CI policy pays a single lump sum on diagnosis of a specified-severity illness (early stage excluded) and then terminates. A disease-specific plan covers multiple stages including early stage, provides structured per-treatment benefits across the journey, and does not end after one payout. For thorough cover of a single disease, the dedicated plan is usually more comprehensive than a CI policy's one payment.

Who Should Buy

Consider a cancer plan with a first-degree family history or known elevated risk, or where your base plan's oncology sub-limits fall short. A diabetes plan if already diagnosed and needing complication cover after the PED wait. A cardiac plan with a strong heart-disease history or thin cardiac sub-limits. A dengue plan for almost anyone in an endemic area — at ₹59–₹682 a year the cost-benefit case is clear.

Tax Treatment (FY 2025-26)

Section 80D — On the Premium

Disease-specific premiums are health insurance and qualify under Section 80D — only in the old regime. Up to ₹25,000 for self, spouse and children under 60; ₹50,000 where a senior is insured; a further ₹25,000/₹50,000 for parents. All health premiums — mediclaim, disease-specific, CI — share this same aggregate limit.

Section 80DDB — On the Bills

A separate deduction for actual out-of-pocket treatment of specified diseases — cancer, chronic renal failure, AIDS, Parkinson's and specified neurological disorders. Up to ₹40,000 below 60; ₹1,00,000 for seniors. It applies to treatment expenses, not premiums, and can be claimed alongside Section 80D.

The Regime Trap

Neither Section 80D nor Section 80DDB is available under the new default regime (Section 115BAC). If you have opted into the new regime, the premium buys protection but no deduction. Weigh the deduction only within an old-regime tax computation.

The Two Deductions Side by Side

Deduction	Covers	Limit
80D	Premiums	₹25k / ₹50k
80DDB	Treatment bills	₹40k / ₹1L

Old regime only. Senior-citizen limits apply where a person aged 60+ is insured (80D) or treated (80DDB). Both are independent and can be claimed together.

Part IV

The Verdict

Depth on one disease. Built on a base that covers the rest.

Part IV: The Verdict · Page 10

30-Second Summary

A disease-specific plan is health insurance concentrated on a single named condition — cancer, diabetes, cardiac disease, kidney failure or a vector-borne illness — following that disease through its whole treatment arc rather than rationing one shared sum insured. Benefit-based versions pay a fixed amount on a defined event and stack across insurers; indemnity versions reimburse real bills and are coordinated to the actual cost. Since IRDAI's April 2024 regulations, the pre-existing wait is capped at 36 months, the moratorium at 60, and insurers can no longer refuse the conditions these plans exist to cover.

The premium is a Section 80D deduction under the old regime, with the separate Section 80DDB available for out-of-pocket treatment of specified diseases. But the single most important point is a matter of sequence: this is a supplement, not a foundation. Comprehensive mediclaim first, as the primary hospitalisation cover; the disease-specific plan second, as a deliberate deep layer over the one risk you have genuine reason to fear. Buy it in the wrong order and you have insured one disease while leaving every other one exposed.

"A disease-specific plan is a scalpel, not a shield. It cuts deep on exactly one condition and leaves the rest untouched. Used as a second layer over solid mediclaim, it is precise and cost-effective. Used as a substitute for it, it is a dangerous illusion of protection. The instrument is sound; only the sequence can be a mistake."
The Final Orientation

The Bottom Line: Put a comprehensive base policy in place first; then add a disease-specific plan only for a risk you can genuinely name — a family cancer history, an existing diabetes diagnosis, a dengue-heavy postcode. Prefer benefit-based cover where stackable payouts matter, and read the waiting periods, disease sub-limits and room-rent terms before you sign. Claim Section 80D only within an old-regime computation, and keep Section 80DDB in mind for actual treatment bills. Verify current premiums, waiting periods and inclusions with the insurer before buying — the worked figures here are illustrative.

ADWIZR · July 2026

Decision Rules

Use Correctly As

✓ A second layer over base mediclaim

✓ Depth on one named, feared disease

✓ A low-cost dengue/malaria top-up

✓ Complication cover for a diagnosis

Misuse Destroys Value

✕ As a replacement for mediclaim

✕ Expecting broad, any-illness cover

✕ Ignoring the 36-month PED wait

✕ Stacking indemnity plans expecting extra

Three Misconceptions

What Buyers Get Wrong

(1) "This can replace my health policy." No — it covers one disease; every other illness stays uninsured. (2) "Two indemnity plans pay me twice." No — coordination of benefits caps the total at the real bill; only benefit-based cover stacks. (3) "I can claim it in the new regime." No — Section 80D applies only under the old regime.

vs Critical Illness

Journey vs One-Shot

Disease-specific: multiple stages, per-treatment benefits, cover that continues — for depth on one disease. Critical illness: a single lump sum on diagnosis, then the policy ends — for a catastrophe cash buffer usable for any purpose. Different tools for different jobs.

1 disease

Scope

Covered in depth

36 mo

PED wait

No refusal, post 2024

80D

Tax

Old regime only

Investor FAQ

Questions Indian Buyers Ask

Six questions, answered directly.

Investor FAQ · Page 12

Frequently Asked Questions

Q1 Can I hold both a comprehensive plan and a cancer-specific plan at once?

Yes — they are separate contracts. For an indemnity-based cancer plan, the total reimbursement from all policies combined cannot exceed your actual hospital bills, because coordination of benefits applies. For a benefit-based cancer plan, each insurer pays its defined benefit independently and the aggregate payout is not capped at actual expenses — which is what makes benefit-based cover stackable.

Q2 I was diagnosed with Type 2 diabetes last year. Can I still buy a diabetes plan?

Yes. IRDAI's April 2024 regulations prohibit insurers from refusing to issue any health insurance policy on grounds of pre-existing conditions, including diabetes. The standard 36-month pre-existing disease waiting period applies before diabetes-related claims are payable, though some dedicated diabetes plans allow a much shorter waiting period — as short as 24 to 31 days for certain complications — in exchange for a higher premium.

Q3 Is a cancer-specific plan the same as a CI policy that covers cancer?

No. A critical illness policy pays a single lump sum on diagnosis of cancer of specified severity, usually excluding early stage, and then terminates. A cancer-specific plan covers multiple stages including early stage and carcinoma-in-situ, provides structured per-treatment benefits across the treatment journey, and does not end after one payout. For thorough cancer financial protection the dedicated cancer plan is usually more comprehensive than a CI policy's single payment.

Q4 My comprehensive plan already covers cancer. Why add a dedicated one?

Standard mediclaim covers cancer hospitalisation up to the sum insured but is not structured around cancer care. Chemotherapy may be treated as day-care with sub-limits, targeted-therapy drugs may not be covered, and a bone-marrow transplant can exhaust the annual sum insured in one treatment cycle. A dedicated cancer plan is built around actual oncology protocols, with per-procedure benefits and continuing cover across the treatment journey.

Q5 Are dengue and malaria plans worth buying given how cheap they are?

At roughly ₹59 to ₹682 a year for standalone cover, the cost-benefit case is clear for most Indians, especially those in tropical regions or high-incidence cities. A fixed benefit of ₹50,000 to ₹1 lakh is paid on a confirmed positive diagnosis with the required hospitalisation, giving immediate liquidity without the friction of reimbursement claims. Treat it as a low-cost top-up, not as your main health cover.

Q6 Is the Section 80DDB deduction separate from Section 80D?

Yes, they are independent. Section 80D covers health insurance premiums, up to ₹25,000, or ₹50,000 where a senior citizen is insured, under the old tax regime. Section 80DDB covers actual out-of-pocket treatment expenses for specified serious diseases such as cancer, chronic renal failure and AIDS, up to ₹40,000, or ₹1,00,000 for senior citizens. A person paying premiums and incurring treatment costs for a covered disease can claim both, subject to their separate limits and filing requirements.

Key Terms & Definitions

Disease-Specific Plan

A health insurance product that provides focused cover for a single named disease or a closely related group — cancer, diabetes, cardiac disease, kidney failure, or vector-borne illness. It tracks the actual treatment journey of that one condition, rather than covering all hospitalisation broadly like standard mediclaim.

Benefit-Based Cover

A structure that pays a pre-agreed fixed sum on a defined event — a diagnosis, a positive test, or a qualifying hospitalisation — regardless of the actual bill. Under IRDAI's 2024 framework, benefit-based claims can be made from multiple insurers at once, making the cover stackable.

Indemnity-Based Cover

A structure that reimburses actual hospitalisation expenses for the named disease, up to the sum insured. Coordination of benefits applies, so the combined reimbursement across all policies held cannot exceed the real hospital bill.

Pre-Existing Disease (PED) Waiting Period

The time a policyholder must hold continuous cover before claims for a pre-existing condition are payable. IRDAI's April 2024 regulations cut the maximum from 48 to 36 months; after that, the pre-existing condition must be fully covered.

Moratorium Period

After 60 months of continuous cover, an insurer cannot deny a covered claim on grounds of non-disclosure or misrepresentation, except in proven cases of fraud. It gives long-term policyholders certainty against late claim disputes.

Section 80DDB

An income-tax deduction (old regime) for actual out-of-pocket treatment expenses for specified serious diseases — cancer, chronic renal failure, AIDS and specified neurological disorders — up to ₹40,000, or ₹1,00,000 for senior citizens. It is separate from, and additional to, the Section 80D premium deduction.